Results 61 to 70 of about 5,604 (187)

Medicinal Delta(9)-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests

open access: yes, 2012
Aims The acute and chronic effects of dronabinol [medicinal ?9-tetrahydrocannabinol (THC)] on actual driving performance and the Standard Field Sobriety Test (SFST) were assessed. It was hypothesized that occasional users would be impaired on these tests
Bosker, W.M.   +9 more
core   +1 more source

Dronabinol Is Not a Game Changer in Pediatric Palliative Care: Results from a Retrospective Study

open access: yesChildren
Background/Objectives: Patients with life-limiting conditions (LLCs) often suffer from restlessness, spasticity, pain, and seizures. Dronabinol (DRB) may have a relieving effect; however, data on the effectiveness of DRB in children with LLCs are limited
Holger Hauch   +3 more
doaj   +1 more source

Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

open access: yesJournal of Pain Research, 2022
Michael A Ueberall,1 Ute Essner,2 Carlos Vila Silván,3 Gerhard HH Mueller-Schwefe4 1Center of Excellence in Health Care Research of the German Pain Association, Institute of Neurological Sciences, Nuernberg, Germany; 2Medical Department, O.
Ueberall MA   +3 more
doaj  

Personality Traits and Their Association With Medication Non‐Adherence in Patients With Multiple Sclerosis

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 7, July 2026.
This cross‐sectional study investigated the role of personality traits in medication non‐adherence among patients with multiple sclerosis. Non‐adherence, reported by 19.9% of the patients, was linked to younger age, lower disease severity, and distinct psychological profiles, including lower self‐directedness, higher shyness, and higher anxiety scores.
Pegah Mashhadiakbar   +12 more
wiley   +1 more source

Patients with chronic pain on opioid therapy taking dronabinol: Incidence of false negatives using radioimmunoassay

open access: yes, 2018
Background: Serum blood toxicology screens are believed to be important to monitor compliance and to identify levels of illicit substances in patients taking opioids for their chronic pain.Methods: In this study, the authors examine the incidence of ...
Edward Michna, MD   +5 more
core   +1 more source

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

open access: yesInternational Journal of Eating Disorders, Volume 59, Issue 7, Page 1576-1587, July 2026.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota   +8 more
wiley   +1 more source

Management Approach for Anorexia in Palliative Care: An Integrative Literature Review / Condutas para o Manejo da Anorexia em Cuidados Paliativos: Revisão Integrativa

open access: yesRevista de Pesquisa Cuidado é Fundamental Online, 2020
Objetivo: Identificar as evidências científicas acerca das condutas para o manejo da anorexia em cuidados paliativos. Métodos: Trata-se de uma revisão integrativa, cujo levantamento bibliográfico dos dados deu-se através da pesquisa em quatro bases de ...
Raquel Bezerra Barbosa de Moura   +5 more
doaj   +1 more source

International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction There have been concerted research efforts internationally to examine the health effects of higher delta‐9‐tetrahydrocannabinol (THC) concentration cannabis products and to design policies to reduce potential negative health effects of their use.
Myfanwy Graham   +3 more
wiley   +1 more source

Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients

open access: yes, 2017
Treatment of neuropathic pain (NP) symptoms associated with multiple sclerosis (MS) is frequently insufficient. Yet, cannabis is still rarely offered for treatment of pain.
Martin Marziniak   +5 more
core   +1 more source

A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis‐Related Safety Signals

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Background The applicability of spontaneous reporting systems such as the US Food and Drug Administration Adverse Event Reporting System (FAERS) to detect cannabis‐related safety signals remains unclear due to the potential for discrepant reporting patterns between pharmaceutical and non‐pharmaceutical cannabis‐derived products (CDPs ...
Priscilla O. M. V. Lopes   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy